Condition

Fibrinolysis clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Fibrinolysis clinical trials that are recruiting, at sites in 4 countries (most in Greece (1), Canada (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Fibrinolysis clinical trials

StudyPhaseWhereStatusRegistered
Comparing tranexamic acid dosing during heart surgery with cardiopulmonary bypass — Ioannina Recruiting Sep 10, 2025
Annexin A2 (ANXA2) gene variants and ischemic stroke risk — Amiens Recruiting Mar 17, 2025
Understanding how drugs work in children — Phoenix, Arizona and 51 other locations Recruiting Feb 20, 2020

All recruiting trials (3)

Related topics

HemorrhageAdrenal InsufficiencyAdverse Drug EventArrythmiaAsthma in ChildrenAttention Deficit Hyperactivity DisorderBlood Coagulation DisorderBronchopulmonary DysplasiaCoagulation DisorderDown SyndromeEdemaHeart FailureHemophiliaHyperphosphatemia

Quick answers

How many Fibrinolysis clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in Greece (1 trial), Canada (1 trial), United States (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.